Small cell lung cancer (SCLC) demonstrated higher levels of SUMO1, SUMO2/3, and UBC9, whereas large cell lung carcinoma (LCC) showed markedly reduced SENP1 expression. This evidence concerns the gene SUMO2 and leukoencephalopathy with calcifications and cysts.